NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

AlloSource AlloSkin™ AC

AlloSkin™ AC is a meshed, dermis-only human skin graft providing off-the-shelf convenience in regenerative technology. Through AlloSource’s proprietary process, the graft is decellularized while preserving the natural biologic components and structure of the dermal matrix. AlloSkin AC is especially suited for OR use as it is designed for a single application, and ideal for acute and chronic wound therapy. The meshed format also encourages fluid drainage from the wound. AlloSkin AC provides a favorable microenvironment for bio-ingrowth to begin revascularization and cellular repopulation. This sterile product is available room temperature, ready-to-use and is pliable to contour to wound topography.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X